medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2007, Número 11-12

Siguiente >>

Medicina & Laboratorio 2007; 13 (11-12)


Del hemograma manual al hemograma de cuarta generación

Campuzano MG

Idioma: Español
Referencias bibliográficas: 171
Paginas: 511-550
Archivo PDF: 3134.83 Kb.


RESUMEN

El hemograma o cuadro hemático es una de las pruebas que más se solicita al laboratorio clínico, y sin duda alguna, la prueba de laboratorio que más aporta al clínico en la evaluación de un paciente. Desde el punto de vista técnico se reconocen seis tipos de hemograma, que van desde los tradicionales que se hacen con métodos manuales hasta los más sofisticados que se hacen con métodos electrónicos que utilizan una combinación de tecnologías. Se establecen los criterios que definen los tipos de hemograma y se analizan los parámetros desde el punto de vista metodológico, los valores de referencia, las indicaciones clínicas y los aspectos críticos de cada parámetro de acuerdo con la metodología utilizada. El médico debe solicitar el hemograma que le permita tener mayor certeza analítica posible en los parámetros reportados y el laboratorio clínico debe hacer la inversión tecnológica que le permita ofrecer resultados lo más precisos y exactos posible.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alberts B. Cells in their social context. In Molecular biology of the cell, Alberts B, Johnson A, Lewis J, Raff M, Robersts K and Walter P. 4th edition, Academic Press; New York, USA. 2002; 1286-1287.

  2. Eadie GS, Brown IW, Jr. Red blood cell survival studies. Blood 1953; 8: 1110-1136.

  3. Bautista AP, Buckler PW, Towler HM, Dawson AA, Bennett B. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets. Br J Haematol 1984; 58: 679-687.

  4. Heilmann E, Friese P, Anderson S, George JN, Hanson SR, Burstein SA, et al. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol 1993; 85: 729-735.

  5. Bounurant MC, Koury MJ. Origin and development of blood cells. In Wintrobe’s clinical hematology, Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F and Glader B. 11th Edition, Lipincott Williams & Wilkins; Philadelphia, PA, USA. 2004; 169-193.

  6. Gulati GL, Hyun BH. The automated CBC. A current perspective. Hematol Oncol Clin North Am 1994; 8: 593-603.

  7. Sociedad Colombiana de Patología Clínica. Manual de Codificación, Nomenclatura, Nivelación y Valores de Exámenes de laboratorio Clínico. Edimeco S.A., Medellín, Colombia. 2007, 1-100.

  8. República de Colombia, Ministerio de Protección Social. Resolución 1896 de 2001 por la cual se sustituye integralmente la Clasificación Única de Procedimientos en Salud.

  9. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 2001; 125: 391-396.

  10. College of American Pathologists. Workload Recording Method & Personnel Management Manual. 1992.

  11. Fajardo Lobo-Guerrero LF. Procedimientos básicos en hematología. In Técnicas de laboratorio en hematología clínica, Restrepo-Mesa A. Sociedad Colombiana de Hematología, Editorial de la Universidad de Anioquia; Medellín, Colombia. 1975; 3-58.

  12. Perkins SL. Examination of the blood and bone marrow. In Wintrobe’s clinical hematology, Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F and Glader B. 11th Edition, Lipincott Williams & Wilkins; Philadelphia, PA, USA. 2004; 16-34.

  13. Bain BJ, Lewis SM, Bates I. Basic haematological techniques. In Dacie and Lewis practical haematology, Lewis SM, Bain BJ and Bates I. 5th edition, Churchill Livingston; Philadelphia, PA, USA. 2006; 26-57.

  14. Cartwright GE. El laboratorio en el diagnóstico hematológico. Barcelona (España). 1973,

  15. Wintrobe MM. Anemia: Classification and treatment on the basis of differences in the average volume and hemoglobin content of the red corpuscles. Arch Intern Med 1934; 54: 256-261.

  16. Coulter WH. High speed automatic blood cell counter and cell size analyzer. Proc Natl Electronics Conf 1956; 12: 1034-1042.

  17. Campuzano-Maya G. El hemograma electrónico. Laboratorio Al Día 1995; 5: 28-41.

  18. Laboratorio Clínico Hematológico. Manual de procedimientos. 2007, Medellín, Colombia.

  19. Pincus MR, Abraham NZ. Interpreting laboratory results. In Henry´s clinical diagnosis and management by laboratory methods, McPherson RA and Pincus MR. 21th edition, Saunders Elsevier; 2007; 76-90.

  20. Bessman JD, Gilmer PR, Jr., Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983; 80: 322-326.

  21. Campuzano-Maya G. El hemograma. Medicina & Laboratorio 1998; 8: 19-32.

  22. Wintrobe M. A simple and accurate hematocrit. J Lab Clin Med 1929; 15: 287-289.

  23. Bull BS, Fujimoto K, Houwen B, Klee G, van Hove L, van Assendelft OW, et al. International Council for Standardization in Haematology (ICSH) recommendations for «surrogate reference» method for the packed cell volume. Lab Hematol 2003; 9: 1-9.

  24. World Health Organization. Recomended method for the determination of packed cell volume by centrifugation (prepared by Expert Pane on cytometry of the International Council for WHO/DIL/00. WHO, Geneva 2000; 1: 1-9.

  25. Fairbanks VF. Nonequivalence of automated and manual hematocrit and erythrocytic indices. Am J Clin Pathol 1980; 73: 55-62.

  26. Pearson TC, Guthrie DL. Trapped plasma in the microhematocrit. Am J Clin Pathol 1982; 78: 770-772.

  27. England JM, Walford DM, Waters DA. Re-assessment of the reliability of the haematocrit. Br J Haematol 1972; 23: 247-256.

  28. D’Onofrio G, Mistretta G, Giordano G, Zini G. Erythropoietic function assessment: Development of methodology-the Sysmex XE-2100TM. Infusion Therapy and Transfusion Medicine 2001; 28: 285-291.

  29. Van den Bossche J, Devreese K, Malfait R, Van de Vyvere M, Wauters A, Neeis H, et al. Reference intervals for a complete blood count determined on different automated haematology analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120. Clin Chem Lab Med 2002; 40: 69-73.

  30. Campuzano-Maya G. Alteraciones del hemograma relacionadas con los contadores de células. Medicina & Laboratorio 2005; 11: 363-384.

  31. Bryner MA, Houwen B, Westengard J, Klein O. The spun micro-haematocrit and mean red cell volume are affected by changes in the oxygenation state of red blood cells. Clin Lab Haematol 1997; 19: 99-103.

  32. Lewis SM. Standardization and harmonization of the blood count: the role of International Committee for Standardization in Haematology (ICSH). Eur J Haematol Suppl 1990; 53: 9-13.

  33. International Committee for Standardization in Haematology; Expert Panel on Haemoglobinometry. Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1986) and specifications for international haemiglobincyanide reference preparation (3rd edition). Clin Lab Haematol 1987; 9: 73-79.

  34. Kickler TS. Clinical analyzers. Advances in automated cell counting. Anal Chem 1999; 71: 363R-365R.

  35. Nakul-Aquaronne D, Sudaka-Sammarcelli I, Ferrero-Vacher C, Starck B, Bayle J. Evaluation of the Sysmex Xe-2100 hematology analyzer in hospital use. J Clin Lab Anal 2003; 17: 113-123.

  36. Gagne C, Auger PL, Moorjani S, Brun D, Lupien PJ. Effect of hyperchylomicronemia on the measurement of hemoglobin. Am J Clin Pathol 1977; 68: 584-586.

  37. Linz LJ. Elevation of hemoglobin, MCH, and MCHC by paraprotein: how to recognize and correct the interference. Clin Lab Sci 1994; 7: 211-212.

  38. Cornbleet J. Spurious results from automated hematology cell analyzers. Lab Med 1983; 14: 509-514.

  39. Wintrobe MM. The size and hemoglobin content of the erythrocyte. J Lab Clin Med 1932; 17: 899-911.

  40. Glader B. Anemia: general considerations. In Wintrobe’s clinical hematology, Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F and Glader B. 11th Edition, Lipincott Williams & Wilkins; Philadelphia, PA, USA. 2004; 947-978.

  41. Reed GF, Lynn F, Meade BD. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002; 9: 1235-1239.

  42. Williams LJ. Cell histograms: New trends in data interpretation and classification. J Med Technol 1984; 1: 189.

  43. Beautyman W, Bills T. Osmotic error in red cell measurements of red cell. Lancet 1974; 2: 905-906.

  44. Savage RA, Hoffman GC. Clinical significance of osmotic matrix errors in automated hematology: the frequency of hyperglycemic osmotic matrix errors producing spurious macrocytosis. Am J Clin Pathol 1983; 80: 861-865.

  45. Holt JT, DeWandler MJ, Arvan DA. Spurious elevation of the electronically determined mean corpuscular volume and hematocrit caused by hyperglycemia. Am J Clin Pathol 1982; 77: 561-567.

  46. Strauchen JA, Alston W, Anderson J, Gustafson Z, Fajardo LF. Inaccuracy in automated measurement of hematocrit and corpuscular indices in the presence of severe hyperglycemia. Blood 1981; 57: 1065-1067.

  47. Beautyman W, Bills T. Osmotic error in erythrocyte volume determinations. Am J Hematol 1982; 12: 383-389.

  48. Hodges RE, Sauberlich HE, Canham JE, Wallace DL, Rucker RB, Mejia LA, et al. Hematopoietic studies in vitamin A deficiency. Am J Clin Nutr 1978; 31: 876-885.

  49. Garcia-Casal MN, Layrisse M, Solano L, Baron MA, Arguello F, Llovera D, et al. Vitamin A and beta-carotene can improve nonheme iron absorption from rice, wheat and corn by humans. J Nutr 1998; 128: 646-650.

  50. West MS, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 1992; 45: 893-909.

  51. Ballas SK, Larner J, Smith ED, Surrey S, Schwartz E, Rappaport EF. The xerocytosis of Hb SC disease. Blood 1987; 69: 124-130.

  52. Groner W, Simson E. Practical guide to modern hematology analyzers. John Wiley and Sons, Chichester, UK. 1995,

  53. Koenn ME, Kirby BA, Cook LL, Hare JL, Hall SH, Barry PM, et al. Comparison of four automated hematology analyzers. Clin Lab Sci 2001; 14: 238-242.

  54. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 1996; 128: 259-269.

  55. Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr 1997; 130: 957-960.

  56. Bessman D. What’s an RDW? Am J Clin Pathol 1981; 76: 242-243.

  57. Walters JG, Garrity PF. RDW-SD and RDW-CV: Their relationship to RBC distribution curves and anisocitosis. Sysmex J Intern 1993; 3: 40-46.

  58. Roberts GT, El Badawi SB. Red blood cell distribution width index in some hematologic diseases. Am J Clin Pathol 1985; 83: 222-226.

  59. Morgan DL, Peck SD. The use of red cell distribution width in the detection of iron deficiency in chronic hemodialysis patients. Am J Clin Pathol 1988; 89: 513-515.

  60. Campuzano-Maya G. Aproximación al diagnóstico etiológico del paciente con anemia. Laboratorio Al Día 1995; 5: 195-204.

  61. Campuzano-Maya G. Cómo llegar al diagnóstico etiológico del paciente con anemia. Anales de la Academia de Medicina de Medellín 1996; 9: 29-36.

  62. Saxena S, Weiner JM, Carmel R. Red blood cell distribution width in untreated pernicious anemia. Am J Clin Pathol 1988; 89: 660-663.

  63. McClure S, Custer E, Bessman JD. Improved detection of early iron deficiency in nonanemic subjects. Jama 1985; 253: 1021-1023.

  64. Patton WN, Cave RJ, Harris RI. A study of changes in red cell volume and haemoglobin concentration during phlebotomy induced iron deficiency and iron repletion using the Technicon H1. Clin Lab Haematol 1991; 13:

  65. Miguel A, Linares M, Miguel A, Miguel-Borja JM. Red cell distribution width analysis in differentiation between iron deficiency and thalassemia minor. Acta Haematol 1988; 80: 59.

  66. Han P, Fung KP. Discriminant analysis of iron deficiency anaemia and heterozygous thalassaemia traits: a 3-dimensional selection of red cell indices. Clin Lab Haematol 1991; 13: 351-362.

  67. Schimenti KJ, Lacerna K, Wamble A, Maston L, Iaffaldano C, Straight M, et al. Reticulocyte quantification by flow cytometry, image analysis, and manual counting. Cytometry B Clin Cytom 1992; 13: 853-862.

  68. Savage RA, Skoog DP, Rabinovitch A. Analytic inaccuracy and imprecision in reticulocyte counting: a preliminary report from the College of American Pathologists Reticulocyte Project. Blood Cells 1985; 11: 97-112.

  69. Lee LG, Chen CH, Chiu LA. Thiazole orange: a new dye for reticulocyte analysis. Cytometry B Clin Cytom 1986; 7: 508-517.

  70. Ferguson DJ, Lee SF, Gordon PA. Evaluation of reticulocyte counts by flow cytometry in a routine laboratory. Am J Hematol 1990; 33: 13-17.

  71. Riley RS, Ben-Ezra JM, Tidwell A, Romagnoli G. Reticulocyte analysis by flow cytometry and other techniques. Hematol Oncol Clin North Am 2002; 16: 373-420, vii.

  72. Inoue H. Overview of automated hematology analyzer XE- 2100. Sysmex J Int 1999; 9: 58-64.

  73. D’Onofrio G, Tichelli A, Foures C, Theodorsen L. Indicators of haematopoietic recovery after bone marrow transplantation: the role of reticulocyte measurements. Clin Lab Haematol 1996; 18 Suppl 1: 45-53.

  74. Grazziutti ML, Dong L, Miceli MH, Cottler-Fox M, Krishna SG, Fassas A, et al. Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients. Bone Marrow Transplant 2006; 37: 403-409.

  75. D’Onofrio G, Kim YR, Schulze S, Lorentz T, Dorner K, Goossens W, et al. Evaluation of the Abbott Cell Dyn 4000 automated fluorescent reticulocyte measurements: comparison with manual, FACScan and Sysmex R1000 methods. Clin Lab Haematol 1997; 19: 253-260.

  76. Sica S, Sora F, Laurenti L, Piccirillo N, Salutari P, Chiusolo P, et al. Highly fluorescent reticulocyte count predicts haemopoietic recovery after immunosuppression for severe aplastic anaemia. Clin Lab Haematol 1999; 21: 387-389.

  77. Metzger DK, Charache S. Flow cytometric reticulocyte counting with thioflavin T in a clinical hematology laboratory. Arch Pathol Lab Med 1987; 111: 540-544.

  78. Brugnara C, Hipp MJ, Irving PJ, Lathrop H, Lee PA, Minchello EM, et al. Automated reticulocyte counting and measurement of reticulocyte cellular indices. Evaluation of the Miles H*3 blood analyzer. Am J Clin Pathol 1994; 102: 623-632.

  79. Lacombe F, Lacoste L, Vial JP, Briais A, Reiffers J, Boisseau MR, et al. Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts. Am J Clin Pathol 1999; 112: 677-686.

  80. Weimann A, Lun S, Muller C, Pratschke J, Reinke P, Lun A. Reticulocytes and their immature fraction do not detect acute rejection after kidney transplantation. Transplant Proc 2007; 39: 514-517.

  81. Grotto HZ, Vigoritto AC, Noronha JF, Lima GA. Immature reticulocyte fraction as a criterion for marrow engraftment. Evaluation of a semi-automated reticulocyte counting method. Clin Lab Haematol 1999; 21: 285-287.

  82. Yu PH, So CC, Wong KF, Lee KC, Chow CS, Yip LK, et al. Automated reticulocyte counting--an evaluation of GEN-S, Cell-Dyn 3500 and Cell-Dyn 4000. Clin Lab Haematol 1999; 21: 145-147.

  83. Canals C, Remacha AF, Sarda MP, Piazuelo JM, Royo MT, Romero MA. Clinical utility of the new Sysmex XE 2100 parameter - reticulocyte hemoglobin equivalent - in the diagnosis of anemia. Haematologica 2005; 90: 1133-1134.

  84. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006; 28: 303-308.

  85. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-833.

  86. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-2411.

  87. Sapojnikov M, Veksler A, Yagil Y, Kogan J, Turkot S, Boris G, et al. Hemodynamic effects of anemia correction by recombinant human erythropoietin in predialysis patients with renal failure. Ren Fail 2005; 27: 199-203.

  88. Tsuchiya K, Saito M, Okano-Sugiyama H, Nihei H, Ando M, Teramura M, et al. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients. Ren Fail 2005; 27: 59-65.

  89. Garzia M, Di Mario A, Ferraro E, Tazza L, Rossi E, Luciani G, et al. Reticulocyte Hemoglobin Equivalent: An Indicator of Reduced Iron Availability in Chronic Kidney Diseases during Erythropoietin Therapy. Lab Hematol 2007; 13: 6-11.

  90. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 1994; 83: 3100-3101.

  91. Brugnara C, Zelmanovic D, Sorette M, Ballas SK, Platt O. Reticulocyte hemoglobin: an integrated parameter for evaluation of erythropoietic activity. Am J Clin Pathol 1997; 108: 133-142.

  92. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998; 28: 1-11.

  93. Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. Jama 1999; 281: 2225-2230.

  94. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000; 37: 93-130.

  95. Eisenstaedt R, Penninx BW, Woodman RC. Anemia in the elderly: Current understanding and emerging concepts. Blood Rev 2006;

  96. Pujade-Lauraine E, Topham C. Once-weekly treatment of anemia in patients with cancer: a comparative review of epoetins. Oncology 2005; 68: 122-129.

  97. Vaupel P, Dunst J, Engert A, Fandrey J, Feyer P, Freund M, et al. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia. Onkologie 2005; 28: 216-221.

  98. Giles I. Hematology automation aids in athletic testing. MLO Med Lab Obs 2005; 37: 22, 24.

  99. Billett HH, Fabry ME, Nagel RL. Hemoglobin distribution width: a rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia. J Lab Clin Med 1988; 112: 339-344.

  100. Liu TC, Seong PS, Lin TK. The erythrocyte cell hemoglobin distribution width segregates thalassemia traits from other nonthalassemic conditions with microcytosis. Am J Clin Pathol 1997; 107: 601-607.

  101. Conway AM, Vora AJ, Hinchliffe RF. The clinical relevance of an isolated increase in the number of circulating hyperchromic red blood cells. J Clin Pathol 2002; 55: 841-844.

  102. Pierre RV. Peripheral blood film review. The demise of the eyecount leukocyte differential. Clin Lab Med 2002; 22: 279-297.

  103. Castro OL, Haddy TB, Rana SR. Age- and sex-related blood cell values in healthy black Americans. Public Health Rep 1987; 102: 232-237.

  104. Wolach B, Ashkenazi M, Grossmann R, Gavrieli R, Friedman Z, Bashan N, et al. Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel. Pediatr Res 2004; 55: 807-813.

  105. Lewis SM. Reference ranges and normal value. In Dacie and Lewis practical haematology, Lewis SM, Bain BJ and Bates I. 5th edition, Churchill Livingston; Philadelphia, PA, USA. 2006; 11-24.

  106. Balloch AJ, Cauchi MN. Reference ranges for haematology parameters in pregnancy derived from patient populations. Clin Lab Haematol 1993; 15: 7-14.

  107. Jia EZ, Yang ZJ, Yuan B, Zang XL, Wang RH, Zhu TB, et al. Relationship between leukocyte count and angiographical characteristics of coronary atherosclerosis. Acta Pharmacol Sin 2005; 26: 1057-1062.

  108. Futterman LG, Lemberg L. The leukocyte count, a measure and predictor of coronary events. Am J Crit Care 2007; 16: 401-404.

  109. Barnard DF, Carter AB, Crosland-Taylor PJ, Stewart JW. An evaluation of the Coulter model S. J Clin Pathol Suppl Coll Pathol 1969; 3: 26-33.

  110. Sharp AA, Ballard BC. An evaluation of the Coulter S counter. J Clin Pathol 1970; 23: 327-335.

  111. Houwen B. The differential cell count. Lab Hematol 2001; 7: 89100.

  112. Cornbleet J, Kessinger S. Evaluation of Coulter S-Plus three-part differential in population with a high prevalence of abnormalities. Am J Clin Pathol 1985; 84: 620-626.

  113. Orser B. Hematology quality control and the Coulter S-Plus II. Am J Med Technol 1983; 49: 643-647.

  114. Griswold DJ, Champagne VD. Evaluation of the Coulter S-Plus IV three-part differential in an acute care hospital. Am J Clin Pathol 1985; 84: 49-57.

  115. Kalish RJ, Becker K. Evaluation of the Coulter S-Plus V three-part differential in a community hospital, including criteria for its use. Am J Clin Pathol 1986; 86: 751-755.

  116. Pagliuca A, Hambley H, Mufti GJ. Coulter S Plus STKR histograms detect spurious elevation of leucocyte and platelet counts associated with cryoglobulinaemia. Blut 1989; 59: 396-397.

  117. Smeets EH, van Wersch JW. Performance of a three-part dif impedance cytometer (Sysmex E-4000) in comparison with a cytochemical cytometer (Technicon H 6000). J Clin Chem Clin Biochem 1988; 26: 531-540.

  118. Payne BA, Pierre RV, Lee WK. Evaluation of the Toa E-5000 Automated Hematology Analyzer. Am J Clin Pathol 1987; 88: 51-57.

  119. Hinchliffe RF, Laycock BJ, Clark SJ, Morton J, Anderson LM, Lilleyman JS. An evaluation of the Sequoia-Turner Cell Dyn 900. Clin Lab Haematol 1985; 7: 157-165.

  120. Simmons A, Leaverton P, Elbert G. Normal laboratory values for differential white cell counts established by manual and automated cytochemical methods (Hemalog D-TM). J Clin Pathol 1974; 27: 55-58.

  121. Hanscheid T, Pinto BG, Cristino JM, Grobusch MP. Malaria diagnosis with the haematology analyser Cell-Dyn 3500: What does the instrument detect? Clin Lab Haematol 2000; 22: 259-261.

  122. Huh J, Jung J, Yoon H, Chung W. Pseudoeosinophilia associated with malaria infection determined in the Sysmex XE-2100 hematology analyzer. Ann Hematol 2005; 84: 400-402.

  123. ICSH. Recommended methods for the visual determination of white cell and platelet counts. 1988, WHO LAB 88, 3. 1988;

  124. Langford K, Luchtman-Jones L, Miller R, Walck D. Performance evaluation of the Sysmex XT-2000i automated hematology analyzer. Lab Hematol 2003; 9: 29-37.

  125. Briggs C, Kunka S, Machin SJ. The most accurate platelet count on the Sysmex XE-2100. Optical or impedance? Clin Lab Haematol 2004; 26: 157-158.

  126. Stanworth SJ, Denton K, Monteath J, Patton WN. Automated counting of platelets on the Bayer ADVIA 120 analyser. Clin Lab Haematol 1999; 21: 113-117.

  127. Picard F, Gicquel C, Marnet L, Guesnu M, Levy JP. Preliminary evaluation of the new hematology analyzer COULTER GEN-S in a university hospital. Clin Chem Lab Med 1999; 37: 681-686.

  128. Grimaldi E, Scopacasa F. Evaluation of the Abbott CELLDYN 4000 hematology analyzer. Am J Clin Pathol 2000; 113: 497-505.

  129. Peng L, Gao X, Jiang H, Peng Z, Su J. Laboratory evaluation of the Sysmex SE-9500 automated haematology analyser. Clin Lab Haematol 2001; 23: 237-242.

  130. Sandhaus LM, Osei ES, Agrawal NN, Dillman CA, Meyerson HJ. Platelet counting by the Coulter LH 750, Sysmex XE 2100, and Advia 120: a comparative analysis using the RBC/platelet ratio reference method. Am J Clin Pathol 2002; 118: 235-241.

  131. Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, et al. Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol 2005; 11: 62-70.

  132. Johannessen B, Roemer B, Flatmoen L, Just T, Aarsand AK, Scott CS. Implementation of monoclonal antibody fluorescence on the Abbott CELL-DYN Sapphire haematology analyser: evaluation of lymphoid, myeloid and platelet markers. Clin Lab Haematol 2006; 28: 84-96.

  133. Campuzano-Maya G. Trombocitopenia: más importante que encontrarla es saber porqué se presenta. Medicina & Laboratorio 2007; 13: 111-125.

  134. Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int J Lab Hematol 2007; 29: 77-91.

  135. Onder O, Weinstein A, Hoyer LW. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents. Blood 1980; 56: 177-182.

  136. Lombarts AJ, de Kieviet W. Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis. Am J Clin Pathol 1988; 89: 634-639.

  137. Ahmed P, Minnich V, Michael JM. Platelet satellitosis with spurious thrombocytopenia and neutropenia. Am J Clin Pathol 1978; 69: 473-474.

  138. Bodensteiner D, Talley R, Rosenfeld C. Platelet satellitism: a possible mechanism. South Med J 1987; 80: 459-461.

  139. Cunningham VL, Brandt JT. Spurious thrombocytopenia due to EDTA-independent cold-reactive agglutinins. Am J Clin Pathol 1992; 97: 359-362.

  140. Threatte GA. Usefulness of the mean platelet volume. Clin Lab Med 1993; 13: 937-950.

  141. Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application. Blood Rev 1993; 7: 104-113.

  142. Trowbridge EA, Martin JF. The platelet volume distribution: a signature of the prethrombotic state in coronary heart disease? Thromb Haemost 1987; 58: 714-717.

  143. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157-161.

  144. Wiwanitkit V. Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost 2004; 10: 175-178.

  145. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol 2005; 128: 698-702.

  146. Bessman JD, Gardner FH. Platelet size in thrombocytopenia due to sepsis. Surg Gynecol Obstet 1983; 156: 177-180.

  147. Bessman JD, Gilmer PR, Gardner FH. Use of mean platelet volume improves detection of platelet disorders. Blood Cells 1985; 11: 127-135.

  148. Macchi I, Chamlian V, Sadoun A, Le Dirach A, Guilhot J, Guilhot F, et al. Comparison of reticulated platelet count and mean platelet volume determination in the evaluation of bone marrow recovery after aplastic chemotherapy. Eur J Haematol 2002; 69: 152-157.

  149. Bessman JD. The relation of megakaryocyte ploidy to platelet volume. Am J Hematol 1984; 16: 161-170.

  150. Berg SL, Steuber CP, Poplack DG, 1155-1162. Clinical manifestations of acute lymphoblastic leukemia. In Hematology. Basic principles and practice, Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. 4th edition, Elseiver, Inc; Philadelphia, Pennsylvania. 2005; 1155-1162.

  151. Miller KB, Daoust PR. Clinical manifestations of acute myeloid leukemia. In Hematology. Basic principles and practice, Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. 4th edition, Elseiver, Inc; Philadelphia, Pennsylvania. 2005; 1071-1097.

  152. De Angelo DJ, R.M. S. Myelodysplastic syndromes: Biology and treatment. In Hematology. Basic principles and practice, Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. 4th edition, Elseiver, Inc; Philadelphia, Pennsylvania. 2005; 1195-1208.

  153. Patel DV, Rai KR. Chronic lymphocytic leukemia. In Hematology. Basic principles and practice, Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. 4th edition, Elseiver, Inc; Philadelphia, Pennsylvania. 2005; 1437-1454.

  154. Zakarija A, Peterson LC, Tallman MS. Hairy cell leukemia. In Hematology. Basic principles and practice, Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. 4th edition, Elseiver, Inc; Philadelphia, Pennsylvania. 2005; 1455-1465.

  155. Karpatkin S, Freedman ML. Hypersplenic thrombocytopenia differentiated from increased peripheral destruction by platelet volume. Ann Intern Med 1978; 89: 200-203.

  156. Osselaer JC, Jamart J, Scheiff JM. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem 1997; 43: 1072-1076.

  157. Bessman JD, Williams LJ, Gilmer PR, Jr. Platelet size in health and hematologic disease. Am J Clin Pathol 1982; 78: 150-153.

  158. Nelson RB, 3rd, Kehl D. Electronically determined platelet indices in thrombocytopenic patients. Cancer 1981; 48: 954-956.

  159. Beyan C, Kaptan K, Ifran A. Platelet count, mean platelet volume, platelet distribution width, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers. J Thromb Thrombolysis 2006; 22: 161-164.

  160. Abe Y, Wada H, Sakakura M, Nishioka J, Tomatsu H, Hamaguchi Y, et al. Usefulness of fully automated measurement of reticulated platelets using whole blood. Clin Appl Thromb Hemost 2005; 11: 263-270.

  161. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992; 98: 637-646.

  162. Richards EM, Baglin TP. Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol 1995; 91: 445-451.

  163. O’Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996; 88: 3288-3298.

  164. Nakamura T, Uchiyama S, Yamazaki M, Okubo K, Takakuwa Y, Iwata M. Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. Thromb Res 2002; 106: 171-177.

  165. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 2004; 126: 861-869.

  166. Lakkis N, Dokainish H, Abuzahra M, Tsyboulev V, Jorgensen J, De Leon AP, et al. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 2004; 44: 2091-2093.

  167. Zucker ML, Murphy CA, Rachel JM, Martinez GA, Abhyankar S, McGuirk JP, et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol 2006; 12: 125-130.

  168. Takami A, Shibayama M, Orito M, Omote M, Okumura H, Yamashita T, et al. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 501-507.

  169. Wang C, Smith BR, Ault KA, Rinder HM. Reticulated platelets predict platelet count recovery following chemotherapy. Transfusion 2002; 42: 368-374.

  170. Stohlawetz P, Stiegler G, Knobl P, Hocker P, Panzer S. The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions. Ann Hematol 1999; 78: 271-273.

  171. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990; 75: 116-121.




2020     |     www.medigraphic.com